Author

M. D. Miranda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. C. Ferreira· 1 shared A. d. P. D. Da Silva· 1 shared A. Owen· 1 shared A. Paccanaro· 1 shared C. Q. Sacramento· 1 shared C. S. da Silva· 1 shared D. C. Bou-Habib· 1 shared D. F. Barreto-Vieira· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. C. Ferreira

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants.

C. Q. Sacramento, N. Fintelman-Rodrigues, S. S. G. Dias, J. R. Temerozo, A. d. P. D. Da Silva, C. S. da Silva, A. C. Ferreira, M. Mattos, V. C. Soares, F. Pereira-Dutra, M. D. Miranda, D. F. Barreto-Vieira, M. A. N. da Silva, S. de Siqueira Santos, M. Torres, , T. M. L. Souza

This paper shows mefloquine inhibits SARS-CoV-2 infection in relevant cells more effectively than chloroquine without promoting viral mutations.

bioRxiv · Jul 21, 2021Microbiology